These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25561419)

  • 21. [Does a reduced kidney function (creatinine clearance 10-15 ml/min), without acidosis, increase the risk for the rise of lactic acidosis caused by metformin?].
    Heine RJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2213. PubMed ID: 12583406
    [No Abstract]   [Full Text] [Related]  

  • 22. [Recommendations for perioperative interruption of metformin medication].
    Maier C; Wulf H
    Dtsch Med Wochenschr; 2001 Oct; 126(43):1222. PubMed ID: 11677651
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk factors for metformin-associated lactic acidosis.
    Beis SJ; Goshman LM; Newkirk GL
    WMJ; 1999; 98(4):56-7. PubMed ID: 10555481
    [No Abstract]   [Full Text] [Related]  

  • 24. Metformin in type 2 diabetes.
    Fox GN
    J Fam Pract; 2004 Nov; 53(11):900. PubMed ID: 15527727
    [No Abstract]   [Full Text] [Related]  

  • 25. Two additional cases of metformin-associated encephalopathy in patients with end-stage renal disease undergoing hemodialysis.
    Kang YJ; Bae EJ; Seo JW; Jeon DH; Cho HS; Kim HJ; Chang SH; Park DJ
    Hemodial Int; 2013 Jan; 17(1):111-5. PubMed ID: 22515914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
    Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
    Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment.
    Bruijstens LA; van Luin M; Buscher-Jungerhans PM; Bosch FH
    Neth J Med; 2008 May; 66(5):185-90. PubMed ID: 18490795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin-associated lactic acidosis in a patient with normal kidney function.
    van Sloten TT; Pijpers E; Stehouwer CD; Brouwers MC
    Diabetes Res Clin Pract; 2012 Jun; 96(3):e57-8. PubMed ID: 21839535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin hydrochloride in patients undergoing myelography.
    Henry WD
    AJR Am J Roentgenol; 2002 May; 178(5):1289; author reply 1289. PubMed ID: 11959752
    [No Abstract]   [Full Text] [Related]  

  • 30. Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients.
    Kosmalski M; Drozdowska A; Sliwinska A; Drzewoski J
    Adv Med Sci; 2012 Jun; 57(1):65-70. PubMed ID: 22543254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of food on the pharmacokinetics of gemigliptin/metformin sustained-release 50/1,000 mg (25/500 mg x 2 tablets) fixeddose combination tablet in healthy male volunteers.
    Choi HY; Noh YH; Kim YH; Kim MJ; Lee SH; Kim JA; Kim B; Lim HS; Bae KS
    Int J Clin Pharmacol Ther; 2014 May; 52(5):381-91. PubMed ID: 24495314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and contrast media.
    Thomsen HS; Morcos SK; Almén T; Aspelin P; Bellin MF; Clément O; Heinz-Peer G; Reimer P; Stacul F; van der Molen AJ; Webb JA
    Radiology; 2010 Aug; 256(2):672-3; author reply 673. PubMed ID: 20656850
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of drugs in chronic renal insufficiency: primum non nocere! (First do not harm!). The paradigmatic cases of azathioprine, metformin and denosumab].
    Locatelli F; Del Vecchio L; La Milia V
    G Ital Nefrol; 2016; 33(5):. PubMed ID: 27796024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin induced lactic acidosis--particularities and course.
    Strugaru AM; Botnariu G; Agoroaei L; Grigoriu IC; Butnaru E
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):1035-42. PubMed ID: 24502087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
    Almirall J; Bricullé M; Gonzalez-Clemente JM
    Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
    [No Abstract]   [Full Text] [Related]  

  • 36. Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):383-94. PubMed ID: 22313172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes.
    Scheen AJ; Paquot N
    Diabetes Metab; 2013 May; 39(3):179-90. PubMed ID: 23528671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin use in patients with diabetes mellitus and heart failure: friend or foe?
    Giamouzis G; Triposkiadis F; Butler J
    J Card Fail; 2010 Mar; 16(3):207-10. PubMed ID: 20206894
    [No Abstract]   [Full Text] [Related]  

  • 39. In brief: New recommendations for use of metformin in renal impairment.
    Med Lett Drugs Ther; 2016 Apr; 58(1493):51. PubMed ID: 27101208
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metformin and contrast media--increased risk of lactic acidosis?].
    Kløw NE; Draganov B; Os I
    Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1829. PubMed ID: 11464691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.